{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "spl_product_data_elements": [
        "ACD-A Anticoagulant Citrate Dextrose Solution Formula A Dextrose Monohydrate ANHYDROUS DEXTROSE SODIUM CITRATE, UNSPECIFIED FORM Anhydrous Citric Acid Anhydrous Citric Acid Anhydrous Citric Acid Water"
      ],
      "spl_unclassified_section": [
        "Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A CAUTION– DO NOT REMOVE UNIT FROM OVERWRAP UNTIL READY FOR USE THE OVERWRAP IS A MOISTURE BARRIER THE INNER BAG MAINTAINS THE STERILITY OF THE PRODUCT STORE AT CONTROLLED ROOM TEMPERATURE CODE 4B7898Q NDC 0942-0641-03 500 mL Fenwal™ Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A EACH 100 mL CONTAINS 2.45 g DEXTROSE (MONOHYDRATE) USP 2.2 g SODIUM CITRATE (DIHYDRATE) USP 730 mg CITRIC ACID (ANHYDROUS) USP STERILE , NONPYROGENIC STERILIZED BY STEAM SINGLE USE CONTAINER DISCARD UNUSED PORTION FOR USE WITH CYTAPHERESIS DEVICE ONLY NOT FOR DIRECT INTRAVENOUS INFUSION DO NOT USE UNLESS SOLUTION IS CLEAR AND NO LEAKS ARE DETECTED AFTER REMOVING OVERWRAP CHECK FOR MINUTE LEAKS BY SQUEEZING INNER BAG FIRMLY IF LEAKS ARE FOUND DISCARD SOLUTION AS STERILITY MAY BE IMPAIRED DISPOSE OF CONTAINER APPROPRIATELY SEE CARTON FOR ADDITIONAL PRODUCT AND COUNTRY SPECIFIC INFORMATION Rx only PL 146 PLASTIC Manufactured by: Baxter Healthcare Corporation 65 Pitts Station Road Marion, North Carolina 28752 MADE IN USA 07-25-57-867 REV: B Manufactured for: Fenwal, Inc. Lake Zurich, IL 60047 USA logo"
      ],
      "package_label_principal_display_panel": [
        "PACKAGE/LABEL DISPLAY PANEL [Enter Package/Label Display Panel here] Anticoagulant Citrate Dextrose Solution USP (ACD) Formula A label"
      ],
      "set_id": "22805f0d-ba58-41ea-b245-19980abcda22",
      "id": "fc8f1ca0-251a-493a-ad8e-defe2a5c7141",
      "effective_time": "20220211",
      "version": "6",
      "openfda": {
        "application_number": [
          "BN160918"
        ],
        "brand_name": [
          "ACD-A"
        ],
        "generic_name": [
          "ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A"
        ],
        "manufacturer_name": [
          "Fenwal, Inc."
        ],
        "product_ndc": [
          "0942-0641"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "ANHYDROUS CITRIC ACID",
          "DEXTROSE MONOHYDRATE",
          "SODIUM CITRATE, UNSPECIFIED FORM"
        ],
        "spl_id": [
          "fc8f1ca0-251a-493a-ad8e-defe2a5c7141"
        ],
        "spl_set_id": [
          "22805f0d-ba58-41ea-b245-19980abcda22"
        ],
        "package_ndc": [
          "0942-0641-03"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175833",
          "N0000175835",
          "N0000175980",
          "N0000008556",
          "N0000175089"
        ],
        "pharm_class_moa": [
          "Acidifying Activity [MoA]",
          "Calcium Chelating Activity [MoA]"
        ],
        "pharm_class_epc": [
          "Calculi Dissolution Agent [EPC]",
          "Anti-coagulant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Coagulation Factor Activity [PE]"
        ],
        "unii": [
          "XF417D3PSL",
          "LX22YL083G",
          "1Q73Q2JULR"
        ]
      }
    }
  ]
}